• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放疗患者纳入临床试验。

Accrual of radiotherapy patients to clinical trials.

作者信息

Lee J Y, Breaux S R

出版信息

Cancer. 1983 Sep 15;52(6):1014-6. doi: 10.1002/1097-0142(19830915)52:6<1014::aid-cncr2820520614>3.0.co;2-j.

DOI:10.1002/1097-0142(19830915)52:6<1014::aid-cncr2820520614>3.0.co;2-j
PMID:6883268
Abstract

Recruitment of patients to clinical trials is a multi-stage process. To participate in a protocol, a patient must meet all the eligibility requirements; the physicians managing the patient must be amenable to enrolling the patient on protocol; and finally, the patient must consent to participate. In 1979, 64 clinical trials were open to patient accrual in the Division of Radiation Oncology, Mallinckrodt Institute of Radiology, St. Louis, Missouri. A total of 1103 cases were reviewed. Two hundred sixty-three patients were eligible for one of the protocols, of whom 124 were successfully recruited. The reasons for ineligibility and nonparticipation are discussed.

摘要

患者进入临床试验是一个多阶段的过程。要参与一项方案,患者必须满足所有入选标准;负责该患者的医生必须愿意让患者按方案入组;最后,患者必须同意参与。1979年,密苏里州圣路易斯市马林克罗特放射研究所放射肿瘤学部有64项临床试验可供患者入组。共审查了1103例病例。263名患者符合其中一项方案的入选标准,其中124名成功入组。本文讨论了不符合入选标准和未参与的原因。

相似文献

1
Accrual of radiotherapy patients to clinical trials.放疗患者纳入临床试验。
Cancer. 1983 Sep 15;52(6):1014-6. doi: 10.1002/1097-0142(19830915)52:6<1014::aid-cncr2820520614>3.0.co;2-j.
2
Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log.
Cancer Treat Rep. 1987 Jun;71(6):559-65.
3
Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.癌症临床试验入组模式的前瞻性评估:识别入组的潜在障碍。
J Clin Oncol. 2001 Mar 15;19(6):1728-33. doi: 10.1200/JCO.2001.19.6.1728.
4
Recruitment of patients to cooperative group clinical trials.患者纳入合作组临床试验。
Cancer Clin Trials. 1980;3(4):381-4.
5
Should women take part in clinical trials in breast cancer? Issues and some solutions.
J Clin Oncol. 1998 Jan;16(1):354-62. doi: 10.1200/JCO.1998.16.1.354.
6
Increasing minority patient participation in cancer clinical trials using oncology nurse navigation.利用肿瘤护士导航增加少数族裔患者参与癌症临床试验。
Am J Surg. 2012 Apr;203(4):415-22. doi: 10.1016/j.amjsurg.2011.02.005. Epub 2011 Oct 13.
7
Computer-based screening of patients with HIV/AIDS for clinical-trial eligibility.基于计算机对艾滋病毒/艾滋病患者进行临床试验资格筛查。
Online J Curr Clin Trials. 1995 Mar 28;Doc No 179:[3347 words; 32 paragraphs].
8
Using OncoDoc as a computer-based eligibility screening system to improve accrual onto breast cancer clinical trials.使用OncoDoc作为基于计算机的资格筛选系统,以提高乳腺癌临床试验的入组率。
Artif Intell Med. 2003 Sep-Oct;29(1-2):153-67. doi: 10.1016/s0933-3657(03)00040-x.
9
The impact of the physician on the accrual to randomized clinical trials in patients with primary operable breast cancer.医生对原发性可手术乳腺癌患者纳入随机临床试验的影响。
Breast. 2005 Aug;14(4):310-6. doi: 10.1016/j.breast.2005.01.004.
10
Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association.招募少数族裔癌症患者参与癌症临床试验:一项由东部肿瘤协作组和美国医学协会参与的试点项目。
J Clin Oncol. 1999 Mar;17(3):1029-39. doi: 10.1200/JCO.1999.17.3.1029.

引用本文的文献

1
Potential Impact of Revised NCI Eligibility Criteria Guidance: Prior Malignancy Exclusion in Breast Cancer Clinical Trials.修订后的 NCI 资格标准指导意见的潜在影响:乳腺癌临床试验中既往恶性肿瘤的排除。
J Natl Compr Canc Netw. 2022 Jul;20(7):792-799.e4. doi: 10.6004/jnccn.2022.7017.
2
Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews.受试者参与临床试验的障碍与促进因素:综述概述
Contemp Clin Trials Commun. 2021 Aug 3;23:100829. doi: 10.1016/j.conctc.2021.100829. eCollection 2021 Sep.
3
Are clinical trial eligibility criteria an accurate reflection of a real-world population of advanced non-small-cell lung cancer patients?
临床试验入选标准能否准确反映晚期非小细胞肺癌患者的真实世界人群?
Curr Oncol. 2018 Aug;25(4):e291-e297. doi: 10.3747/co.25.3978. Epub 2018 Aug 14.
4
Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.胸部肿瘤临床试验的入选标准和要求继续增加数量和复杂性。
J Thorac Oncol. 2017 Oct;12(10):1489-1495. doi: 10.1016/j.jtho.2017.07.020. Epub 2017 Aug 9.
5
Temporal Trends and Predictors for Cancer Clinical Trial Availability for Medically Underserved Populations.医疗服务不足人群癌症临床试验可及性的时间趋势及预测因素
Oncologist. 2015 Jun;20(6):674-82. doi: 10.1634/theoncologist.2015-0083. Epub 2015 May 27.
6
Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.既往癌症对晚期肺癌预后的影响:对临床试验入组资格和入组率的意义。
J Natl Cancer Inst. 2015 Feb 9;107(4). doi: 10.1093/jnci/djv002. Print 2015 Apr.
7
Impact of prior cancer on eligibility for lung cancer clinical trials.既往癌症对肺癌临床试验资格的影响。
J Natl Cancer Inst. 2014 Sep 24;106(11). doi: 10.1093/jnci/dju302. Print 2014 Nov.
8
Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.治疗性临床试验入组障碍:在资格评估时确定的非裔美国人和白人癌症患者之间的差异。
Clin Trials. 2012 Dec;9(6):788-97. doi: 10.1177/1740774512458992. Epub 2012 Oct 2.
9
Testing the utility of a cancer clinical trial specific Question Prompt List (QPL-CT) during oncology consultations.在肿瘤学咨询中测试癌症临床试验专用问题提示清单 (QPL-CT) 的效用。
Patient Educ Couns. 2012 Aug;88(2):311-7. doi: 10.1016/j.pec.2012.02.009. Epub 2012 Mar 4.
10
Enhancing decision making about participation in cancer clinical trials: development of a question prompt list.提高癌症临床试验参与决策:问题提示清单的制定。
Support Care Cancer. 2011 Aug;19(8):1227-38. doi: 10.1007/s00520-010-0942-6. Epub 2010 Jul 1.